Dave, some folks keep talking about missed milestones, but other than the July over hyped date and pump by money runners, what has been missed in Q3 & Q4?

The one milestone that is coming due quickly is to launch Lympro by the end of the year. Since there won't be TV commercials or blimps announcing Lympro is now available, "launching" could be/mean a lot of things.

The company changed their approach a while back to provide a high-level view of what's to come, without pinning themselves to a concrete date. Maybe because of all the complaining on the MB. Reason why you didn't see revenue projections I assume.